907 results on '"Thaker, Premal H"'
Search Results
152. Treatment patterns among patients with advanced/recurrent endometrial cancer in the United States.
153. Rural residence is related to shorter survival in epithelial ovarian cancer patients
154. Assessing comprehensive care deficits in United States (U.S.) ovarian cancer programs to inform quality improvement initiatives.
155. Reasons for first-line maintenance therapy discontinuation among patients with newly diagnosed advanced ovarian cancer treated in real-world settings.
156. The value of perioperative imaging in patients with uterine sarcomas
157. Postmenopausal Invasive Endometriosis Requiring Supralevator Pelvic Exenteration
158. Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancer
159. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer
160. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients
161. Wilms’ Tumor 1 Protein and Estrogen Receptor Beta Expression are Associated with Poor Outcomes in Uterine Carcinosarcoma
162. Text-message-based behavioral weight loss for endometrial cancer survivors with obesity: A randomized controlled trial
163. GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation Study
164. The Role of Psychologic Stress in Cancer Initiation: Clinical Relevance and Potential Molecular Mechanisms
165. Uterine carcinosarcomas: From pathology to practice
166. Abstract 2202: Genetic characterization of metastasis and prognosis in high-grade serous ovarian cancer
167. Lower Uterine Segment Involvement is Associated with Poor Outcomes in Early-Stage Endometrioid Endometrial Carcinoma
168. 86 - Carcinoma of the Ovaries and Fallopian Tubes
169. Mitochondria in epithelial ovarian carcinoma exhibit abnormal phenotypes and blunted associations with biobehavioral factors
170. A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy
171. Real-world progression-free survival among patients with newly diagnosed advanced ovarian cancer: Does maintenance therapy work?
172. NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.
173. Association of the presence of estrogen and progesterone receptors in uterine carcinosarcoma with improved survival and increased immunogenicity.
174. Treatment patterns among patients with advanced/recurrent endometrial cancer in the United States.
175. Phase 1b study of GAS6/AXL inhibitor (AVB-500) in recurrent, platinum-resistant ovarian carcinoma.
176. Quantification of ovarian lesion and fallopian tube vasculature using optical-resolution photoacoustic microscopy.
177. Positive Psychosocial Factors and Oxytocin in the Ovarian Tumor Microenvironment
178. Impact of employment and insurance status on distress in gynecologic oncology patients
179. Obese endometrial cancer survivors’ perceptions of weight loss strategies and characteristics that may influence participation in behavioral interventions
180. An Exploratory Study of Neoadjuvant Cetuximab Followed by Cetuximab and Chemoradiotherapy in Women With Newly Diagnosed Locally Advanced Cervical Cancer.
181. Chronic difficulties are associated with poorer psychosocial functioning in the first year post‐diagnosis in epithelial ovarian cancer patients
182. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
183. Impact of vessel maturation on antiangiogenic therapy in ovarian cancer
184. Contributors
185. Molecular Oncology in Gynecologic Cancer
186. Improving The Quality of Care for Persons With Advanced Epithelial Ovarian Cancer
187. Ovarian Tumor Mitochondria Exhibit Abnormal Phenotypes and Blunted Associations with Biobehavioral Factors
188. The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer
189. Endometrial Cancer Surveillance Counterpoint: USA
190. Disclosing a Diagnosis of Cancer: Considerations Specific to Gynecologic Oncology Patients
191. Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis
192. SUPPORTIVE CARE
193. DICER1 Expression and Outcomes in Endometrioid Endometrial Adenocarcinoma
194. The Effects of Body Mass Index on Complications and Survival Outcomes in Patients With Cervical Carcinoma Undergoing Curative Chemoradiation Therapy
195. State of the science: Uterine sarcomas: From pathology to practice
196. A fellow-run clinic achieves similar patient outcomes as faculty clinics: A safe and feasible model for gynecologic oncology fellow education
197. Abstract CT124: First-in-human study of SC-004, an antibody-drug conjugate targeting CLDN6/9, in patients with epithelial ovarian cancers
198. Epithelial‐mesenchymal transition polarization in ovarian carcinomas from patients with high social isolation
199. Abstract A17: Characterization of primary-metastasis pairs in high-grade serous ovarian cancer with short- and long-term survival
200. Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.